Varenicline improves motor and cognitive symptoms in early Huntington's disease

The aim of this study was to describe the effects of varenicline, a smoking cessation aid that acts as a nicotinic agonist, on cognitive function in patients with early clinical Huntington's disease (HD) who were current smokers. Three gene-positive patients transitioning to symptomatic HD were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychiatric disease and treatment 2016-01, Vol.12, p.2381-2386
Hauptverfasser:	McGregor, Ailsa L, Dysart, Jo, Tingle, Malcolm D, Russell, Bruce R, Kydd, Rob R, Finucane, Gregory
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Anxiety Apathy Brain research Case Series Clinical significance Cognition & reasoning Cognitive ability Education Emotions Executive function High definition television Huntingtons disease Nicotine Patients Smoking cessation Smoking cessation products Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!